SUMOylation and coupling of eNOS mediated by PIAS1 contribute to maintenance of vascular homeostasis
The FASEB Journal · 2024
DOI: 10.1096/fj.202301963r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2024. Verfasst von Li Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Provincial Key Laboratory of Basic Pharmacology, Nanchang University, Nanchang, Jiangxi, P.R. China. Hauptthemen laut MEDLINE: Homeostasis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Natural Science Foundation of Jiangxi Province (Jiangxi Natural Science Foundation), Jiangxi Administrtion of Traditional Chinese Medicine Science and Technology Project, MOST | National Natural Science Foundation of China (NSFC).
Abstract (Originalsprache)
Endothelial dysfunction (ED) is commonly considered a crucial initiating step in the pathogenesis of numerous cardiovascular diseases. The coupling of endothelial nitric oxide synthase (eNOS) is important in maintaining normal endothelial functions. However, it still remains elusive whether and how eNOS SUMOylation affects the eNOS coupling. In the study, we investigate the roles and possible action mechanisms of protein inhibitor of activated STAT 1 (PIAS1) in ED. Human umbilical vein endothelial cells (HUVECs) treated with palmitate acid (PA) in vitro and ApoE −/− mice fed with high‐fat diet (HFD) in vivo were constructed as the ED models. Our in vivo data show that PIAS1 alleviates the dysfunction of vascular endothelium by increasing nitric oxide (NO) level, reducing malondialdehyde (MDA) level, and activating the phosphatidylinositol 3‐kinase‐protein kinase B‐endothelial nitric oxide synthase (PI3K‐AKT‐eNOS) signaling in ApoE −/− mice. Our in vitro data also show that PIAS1 can SUMOylate eNOS under endogenous conditions; moreover, it antagonizes the eNOS uncoupling induced by PA. The findings demonstrate that PIAS1 alleviates the dysfunction of vascular endothelium by promoting the SUMOylation and inhibiting the uncoupling of eNOS, suggesting that PIAS1 would become an early predictor of atherosclerosis and a new potential target of the hyperlipidemia‐related cardiovascular diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Provincial Key Laboratory of Basic Pharmacology, Nanchang University, Nanchang, Jiangxi, P.R. China.
- Department of Pharmacology, School of Pharmacy, Nanchang University, Nanchang, Jiangxi, P.R. China.
ORCID-Profile: Li Wang, Wenjing Zeng, Chaowen Wang, Yanli Lu, Xiaowei Xiong, Sheng Chen, Qianqian Huang, Feixing Yan, Qiren Huang
Förderung
- Natural Science Foundation of Jiangxi Province (Jiangxi Natural Science Foundation)
- Jiangxi Administrtion of Traditional Chinese Medicine Science and Technology Project
- MOST | National Natural Science Foundation of China (NSFC)
- National Natural Science Foundation of China
Zitieren
APA
Wang, L., Zeng, W., Wang, C., Lu, Y., Xiong, X., Chen, S., Huang, Q., Yan, F., & Huang, Q. (2024). SUMOylation and coupling of eNOS mediated by PIAS1 contribute to maintenance of vascular homeostasis. The FASEB Journal. https://doi.org/10.1096/fj.202301963r
Vancouver
Wang L, Zeng W, Wang C, Lu Y, Xiong X, Chen S, et al. SUMOylation and coupling of eNOS mediated by PIAS1 contribute to maintenance of vascular homeostasis. The FASEB Journal. 2024. doi:10.1096/fj.202301963r
BibTeX
@article{Wang2024,
author = {Wang, Li and Zeng, Wenjing and Wang, Chaowen and Lu, Yanli and Xiong, Xiaowei and Chen, Sheng and Huang, Qianqian and Yan, Feixing and Huang, Qiren},
title = {SUMOylation and coupling of eNOS mediated by PIAS1 contribute to maintenance of vascular homeostasis},
journal = {The FASEB Journal},
year = {2024},
doi = {10.1096/fj.202301963r}
}
EUVIMED